Delivery Order SPE2DB22D2211-SPE2DB23FPFF9
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Pulmozyme 1 mg/ml ampoules (2.5 ml) to the Defense Logistics Agency (DLA), a major supply chain management agency that supports the U.S. Department of Defense (DoD) and other government organizations. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Amerisourcebergen Corporation, one of the largest drug distributors globally. The contract has a ceiling value of $13,470.30 and is a Firm Fixed...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampuls. The contract, valued at $32,686.58, is a firm-fixed-price delivery order with an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract is a Delivery Order with a Firm Fixed Price of $25,335.45 and a period of performance through November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a ceiling value of $5,344.56 and an ultimate completion date of April 13, 2022. The contract is a Delivery Order under a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $31,801.68 and is a firm-fixed-price delivery order with a completion date of September 13, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor that serves federal government agencies. The contract, valued at $4,604.30, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical....
- This federal contract award is for the delivery of Pulmozyme, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $13,812.90, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of March 27, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml to the Defense Logistics Agency (DLA). The $25,667.44 firm-fixed-price contract has an ultimate completion date of December 27, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,881.52, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,730.01 and an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself...